Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa
Autor: | for Germs-Sa, Sophie Candfield, Charlotte Sriruttan, Verushka Chetty, Sandra Toro-Silva, Vanessa Quan, Alison D. Grant, Violet N. Chihota, Nelesh P. Govender, Anna Vassall |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Male
RNA viruses Pediatrics Health Care Providers Nurses Meningitis Cryptococcal Pathology and Laboratory Medicine South Africa 0302 clinical medicine Immunodeficiency Viruses Maintenance therapy Infectious Diseases of the Nervous System Interquartile range Antiretroviral Therapy Highly Active Reflexes HIV Seropositivity Health care Medicine and Health Sciences Medical Personnel 030212 general & internal medicine Multidisciplinary Fungal Diseases Eukaryota HIV diagnosis and management Cryptococcosis Middle Aged Patient Discharge Hospitals 3. Good health Hospitalization Cryptococcal Meningitis Professions Treatment Outcome Infectious Diseases Neurology Medical Microbiology Viral Pathogens Viruses Critical Pathways Medicine Female Pathogens medicine.symptom Meningitis Research Article Adult medicine.medical_specialty Science 030231 tropical medicine Microbiology Asymptomatic 03 medical and health sciences Retroviruses medicine Humans Lost to follow-up Microbial Pathogens Clinical Audit business.industry Lentivirus Organisms Fungi Biology and Life Sciences HIV Patient Acceptance of Health Care medicine.disease Diagnostic medicine Integrated care Health Care Cryptococcus Health Care Facilities People and Places Population Groupings Health Facilities Patient Care business Follow-Up Studies Neuroscience |
Zdroj: | PLoS ONE, Vol 14, Iss 12, p e0225742 (2019) PLoS ONE |
ISSN: | 1932-6203 |
Popis: | Introduction Cryptococcus causes 15% of AIDS-related deaths and in South Africa, with its high HIV burden, is the dominant cause of adult meningitis. Cryptococcal meningitis (CM) mortality is high, partly because patients enter care with advanced HIV disease and because of failure of integrated care following CM diagnosis. We evaluated pathways to hospital care, missed opportunities for HIV testing and initiation of care. Methods We performed a cross-sectional study at five public-sector urban hospitals. We enrolled adults admitted with a first or recurrent episode of cryptococcal meningitis. Study nurses conducted interviews, supplemented by a prospective review of medical charts and laboratory records. Results From May to October 2015, 102 participants were enrolled; median age was 40 years (interquartile range [IQR] 33.9–46.7) and 56 (55%) were male. In the six weeks prior to admission, 2/102 participants were asymptomatic, 72/100 participants sought care at a public-sector facility, 16/100 paid for private health care. The median time from seeking care to admission was 4 days (IQR, 0–27 days). Of 94 HIV-seropositive participants, only 62 (66%) knew their status and 41/62 (66%) had ever taken antiretroviral treatment. Among 13 participants with a known previous CM episode, none were taking fluconazole maintenance therapy. In-hospital management was mostly amphotericin B; in-hospital mortality was high (28/92, 30%). Sixty-four participants were discharged, 92% (59/64) on maintenance fluconazole, 4% (3/64) not on fluconazole and 3% (2/64) unknown. Twelve weeks post-discharge, 31/64 (48%) participants were lost to follow up. By 12 weeks post discharge 7/33 (21%) had died. Interviewed patients were asked if they were still on fluconazole, 11% (2/18) were not. Conclusions Among hospitalised participants with CM, there were many missed opportunities for HIV care and linkage to ART prior to admission. Universal reflex CrAg screening may prompt earlier diagnosis of cryptococcal meningitis but there is a wider problem of timely linkage to care for HIV-seropositive people. |
Databáze: | OpenAIRE |
Externí odkaz: |